|
| Status |
Public on May 13, 2024 |
| Title |
Immunologic adaptation following recombinant amphiregulin ( rAREG) exposure in high grade serous ovarian cancer cell lines |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
770 genes as well as pathways were deternined in high grade serous ovarian cancer cell lines, OVCAR8WT and PEA1 cells stimulated with either BSA control or recombinant AREG (rAREG)
n/a
|
| |
|
| Overall design |
A total of 12 samples were included in this experiment; OVCAR8WT cells stimulated with BSA control , OVCAR8WT cells stimulated with rAREG, PEA1 cells stimulated with BSA control, PEA1 cells stimulated with rAREG. All treatments were performed at 2 hour timepoints, with 3 biological replicates for each treatment.
|
| |
|
| Contributor(s) |
James NE, Ebott J, Schorl C |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Jan 03, 2024 |
| Last update date |
May 13, 2024 |
| Contact name |
Nicole Elizabeth James |
| E-mail(s) |
nicole_james@brown.edu
|
| Phone |
401-406-1642
|
| Organization name |
Women and Infants Hospital
|
| Department |
OB/GYN
|
| Lab |
Molecular Therapeutics Laboratory
|
| Street address |
200 Chestnut Street
|
| City |
Providence |
| State/province |
Rhode Island |
| ZIP/Postal code |
02903 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL27956 |
NanoString Human nCounter PanCancer IO 360 Panel |
|
| Samples (12)
|
|
| Relations |
| BioProject |
PRJNA1060734 |
Less...
More...